BioSpace News Archive

Renowned New York City cosmetic surgeons Drs. Christopher Chia and Spero Theodorou of bodySCULPT® invented a revolutionary technique called the awake Brazilian Butt Lift (BBL), otherwise known as BBL under Local Anesthesia (BBLULA).

Amgen will present at the 37th Annual J.P. Morgan Healthcare Conference at 8:30 a.m. PT on Tuesday, Jan. 8, 2019, in San Francisco. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference.

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform, today provided a year-end 2018 corporate update.

ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2019 on Thursday, January 24, 2019, after the New York Stock Exchange closes.

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Rebecca (Beckie) Robertson was appointed as an independent member of its board of directors.

Patented peptides could be used to treat cancer and infectious diseases

CPC (Colder Products Company), part of Dover (NYSE: DOV) and maker of genderless AseptiQuik® sterile connectors, introduces a 1-1/2" sanitary termination to deliver higher flow rates for high-volume, large-flow transfer lines in full-scale bioprocessing and biopharmaceutical operations.

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 12:00 Noon PST on Wednesday, January 9,

Demand for liver transplants is much higher than organ supply, resulting in approximately 2,400 deaths every year. Also problematic is the current model used to identify and prioritize the “sickest” patients, which does not allow for equitable access to all waitlisted candidates, with a particular disadvantage to women.

Verily, an Alphabet company, today announced a $1 billion investment round, led by Silver Lake, as it advances plans on business strategies that are additive and complementary to its current life sciences portfolio.